Clincosm LogoSign in Get a demo

pulmonary disease, chronic obstructive (copd)

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real-world, 52-week Prospective Study to Capture Reasons for

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive (COPD)
  • Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
  • (no location specified)
Jun 13, 2023

COPD-Related Physiology and the Brain

Recruiting
  • Pulmonary Disease, Chronic Obstructive (COPD)
  • Cognitive Impairment
  • Neuropsychological Assessment
  • +8 more
  • Iowa City, Iowa
    Carinda Linkenmeyer
Apr 21, 2022

Pulmonary Disease, Chronic Obstructive (COPD) Trial in Argentina (Breezhaler®, Ellipta®, Handihaler®)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive (COPD)
  • Breezhaler®
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +4 more
Jun 25, 2018

Pulmonary Disease, Chronic Obstructive (COPD) Trial in Argentina (Patient preference questionnaire)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive (COPD)
  • Patient preference questionnaire
  • Caba, Buenos Aires, Argentina
  • +9 more
Nov 14, 2017

Pulmonary Disease, Chronic Obstructive (COPD) Trial in Barcelona (enose)

Unknown status
  • Pulmonary Disease, Chronic Obstructive (COPD)
  • enose
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Sep 7, 2016

Pulmonary Disease, Chronic Obstructive (COPD) Trial in Kötschach, Klagenfurt, Villach (self-monitoring for patients with severe

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive (COPD)
  • self-monitoring for patients with severe COPD
  • nurse-monitoring for patients with severe COPD
  • Kötschach, Carintha, Austria
  • +2 more
Jul 1, 2015